Category: Health
-
Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth
SINGAPORE, Oct. 1, 2026 /PRNewswire/ — Emerald Clinical Trials, a leading global clinical research organization anchored in Asia-Pacific, today announced the appointment of Michael Stibilj as Chief Executive Officer, effective 1 October 2026. The appointment marks the beginning of the company’s nex…
-
IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution
SYDNEY, Oct. 1, 2026 /PRNewswire/ — IMG (International Medical Group) is excited to announce the successful completion of its acquisition of World Nomads.First announced in February 2026, the acquisition strengthens IMG’s global travel insurance distribution capabilities and expands its presence in…
-
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal’s dedicated sterile injectable facility in Lexington, Kentucky. This partnership addresses ongoing cycl…
-
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure.With its investment through the Life Sciences Scale-Up Fund, the Ontario government is supporting healthcare innovation and reinforcing its province’s leadership position in t…
-
CAS announces collaboration with Novartis to advance AI-ready reaction informatics
Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis COLUMBUS, Ohio, Sept. 29, 2026 /PRNewswire/ — CAS, a division of the American Chemical Society, today announced a collaboration with Novartis Biomedic…
-
A Right-Sided Heart, A 3kg Tumour: A Rare Surgery at Zydus Hospital, Ahmedabad Gives An 11-Year-Old a New Life
Maximally invasive to minimally invasive thoracic tumours: a typical week’s workAHMEDABAD, India, Sept. 25, 2026 /PRNewswire/ — Lung and thoracic cancers are rising rapidly in India with a sevenfold increase since the last decade. Nearly three-quarters of patients are being diagnosed only after the…
-
Windsor Capital Completes $50 Million Strategic Investment in Space Labs
Investment for a 4.9% minority stake implies an approximately $1 billion post-money valuation for the Slovenian technology company.HONG KONG and LJUBLJANA, Slovenia, Sept. 24, 2026 /PRNewswire/ — Windsor Capital today announced the completion of a $50 million strategic investment in Space Labs d.o….
-
NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress
National Cancer Control Plans can and should include regionally appropriate guidelines according to abstracts presented by the National Comprehensive Cancer Network during global event hosted by the Union of International Cancer Control.PLYMOUTH MEETING, Pa. and HONG KONG, Sept. 24, 2026 /PRNewswire…
-
Basecamp Research raises $140M to advance AI-designed therapeutics
Oversubscribed Series C led by S32 with backing from NVIDIA and othersFunding will advance a pipeline of EDEN-designed therapeutics, starting with in vivo cell therapy, and expand pharmaceutical partnershipsThe company has demonstrated strong preclinical results across multiple modalities and diseas…
-
Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent
FDA Clearance and CE Mark Complete Aptiva’s Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing SAN DIEGO, Sept. 23, 2026 /PRNewswire/ — Werfen today announced that its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin A (IgA) Reagent has received both U.S….
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.